Suchergebnisse - "Anurag, Meenakshi"

PubPharm (8)

1

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Ma, C. | Suman, V. | Sanati, S. | +27

2

Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer

enthalten in: Cancer research | 2022

von Kalra, R. | Chen, C. | Wang, J. | +11

3

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Suman, V. | Du, L. | Hoskin, T. | +6

4

A proteogenomic portrait of lung squamous cell carcinoma

enthalten in: Cell | 2021

von Satpathy, S. | Krug, K. | Jean Beltran, P. | +160

5

Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

enthalten in: Cancer cell | 2021

von Huang, C. | Chen, L. | Savage, S. | +167

6

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

enthalten in: Cell | 2020

von Krug, K. | Jaehnig, E. | Satpathy, S. | +88

7

Microscaled proteogenomic methods for precision oncology

enthalten in: Nature communications | 2020

von Satpathy, S. | Jaehnig, E. | Krug, K. | +30

8

The prognostic effects of somatic mutations in ER-positive breast cancer

enthalten in: Nature communications | 2018

von Griffith, O. | Spies, N. | Anurag, M. | +30

ErratumIn: Nat Commun. 2018 Nov 14;9(1):4850. - PMID 30429476

1
[1]